Evidence map›Paper›PMID 27402752›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Two interferon-independent double-stranded RNA-induced host defense strategies suppress the common cold virus at warm temperature.

Ellen F Foxman, James A Storer, Kiran Vanaja, Andre Levchenko, Akiko Iwasaki

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Article
  2. Temperature and developmental stage govern intestinal susceptibility to human coronavirus 229E.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ellen F FoxmanDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520; Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT 06520;
James A StorerDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520;
Kiran VanajaDepartment of Biomedical Engineering, Systems Biology Institute, Yale University, Yale University School of Medicine, New Haven, CT 06520;
Andre LevchenkoDepartment of Biomedical Engineering, Systems Biology Institute, Yale University, Yale University School of Medicine, New Haven, CT 06520;
Akiko IwasakiDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520; Howard Hughes Medical Institute, New Haven, CT 06520 akiko.iwasaki@yale.edu.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Pathology Tissue Services Shared ResourceP30CA016359 · NCI · YALE UNIVERSITY · PI DAVID L RIMM · 1985 to 2026
$85.0M
IMMUNOHEMATOLOGY/TRANSFUSION MEDICINE RESEARCH TRAININGT32HL007974 · NHLBI · YALE UNIVERSITY · PI JEANNE E HENDRICKSON, Diane S Krause · 2001 to 2026
$8.1M
Immunity to Genital Herpes Simplex-2R01AI054359 · NIAID · YALE UNIVERSITY · PI IWASAKI, AKIKO · 2004 to 2019
$5.2M
Viral Recognition by plasmacytoid dendritic cellR01AI064705 · NIAID · YALE UNIVERSITY · PI IWASAKI, AKIKO · 2006 to 2015
$3.9M
Information tranfer in NF-kappaB and MAPK pathwaysR01GM072024 · NIGMS · YALE UNIVERSITY · PI LEVCHENKO, ANDRE · 2004 to 2019
$3.9M
Cell Death and Cross-Protection in Rhinovirus InfectionK08AI119139 · NIAID · YALE UNIVERSITY · PI FOXMAN, ELLEN FLESCHER · 2015 to 2019
$947k
NCATS NIH HHS UL1 TR001863NCI NIH HHS P30 CA016359NHLBI NIH HHS T32 HL007974NIAID NIH HHS K08 AI119139NIAID NIH HHS R01 AI054359NIAID NIH HHS R01 AI064705NIGMS NIH HHS R01 GM072024
6 · The paper itself

Abstract

Most strains of rhinovirus (RV), the common cold virus, replicate better at cool temperatures found in the nasal cavity (33-35 °C) than at lung temperature (37 °C). Recent studies found that although 37 °C temperature suppressed RV growth largely by engaging the type 1 IFN response in infected epithelial cells, a significant temperature dependence to viral replication remained in cells devoid of IFN induction or signaling. To gain insight into IFN-independent mechanisms limiting RV replication at 37 °C, we studied RV infection in human bronchial epithelial cells and H1-HeLa cells. During the single replication cycle, RV exhibited temperature-dependent replication in both cell types in the absence of IFN induction. At 37 °C, earlier signs of apoptosis in RV-infected cells were accompanied by reduced virus production. Furthermore, apoptosis of epithelial cells was enhanced at 37 °C in response to diverse stimuli. Dynamic mathematical modeling and B cell lymphoma 2 (BCL2) overexpression revealed that temperature-dependent host cell death could partially account for the temperature-dependent growth observed during RV amplification, but also suggested additional mechanisms of virus control. In search of a redundant antiviral pathway, we identified a role for the RNA-degrading enzyme RNAseL. Simultaneous antagonism of apoptosis and RNAseL increased viral replication and dramatically reduced temperature dependence. These findings reveal two IFN-independent mechanisms active in innate defense against RV, and demonstrate that even in the absence of IFNs, temperature-dependent RV amplification is largely a result of host cell antiviral restriction mechanisms operating more effectively at 37 °C than at 33 °C.

Indexed as

TemperatureA549 CellsApoptosisBronchiCells, CulturedCommon ColdEpithelial CellsGene ExpressionHeLa CellsHumansInterferonsRespiratory MucosaRhinovirusRNA, Double-StrandedVirus ReplicationInterferonsRNA, Double-Strandedapoptosisinnate immunityrespiratory immunityrhinovirusRNaseL

Identifiers

PMID27402752
PMCPMC4968739

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.